首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1989045

NeuroCalm技術市場預測至2034年－按產品類型、組件、技術、應用、最終用戶、分銷管道和地區分類的全球分析

NeuroCalm Tech Market Forecasts to 2034 - Global Analysis By Product Type, Component, Technology, Application, End User, Distribution Channel and By Geography

出版日期: 2026年03月17日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，預計到 2026 年，全球神經鎮靜技術市場規模將達到 9 億美元，並在預測期內以 15.7% 的複合年成長率成長，到 2034 年將達到 31 億美元。

NeuroCalm Tech 指的是一類基於神經科學的設備和數位平台，旨在透過非侵入性干預來監測、調節和改善大腦及心理健康。這些解決方案包括基於腦電圖 (EEG) 的頭戴式裝置、經顱刺激設備、智慧睡眠最佳化系統以及人工智慧驅動的認知健康應用程式，它們協同工作，幫助解決焦慮症、睡眠障礙、注意力不足過動症 (ADHD) 和創傷後壓力症候群 (PTSD) 等問題。透過結合穿戴式硬體、自適應軟體和遠端醫療服務，NeuroCalm Tech 使個人、臨床醫生和機構能夠以積極主動且個人化的方式提升心理表現和神經系統健康。

人們對心理健康的認知不斷提高，推動了心理健康技術的普及。

全球對精神健康障礙及其經濟和社會影響的認知不斷提高，推動了對技術主導健康解決方案的強勁需求。工作場所壓力水平的不斷攀升、焦慮和睡眠障礙的盛行率上升，以及人們越來越願意投資於預防性精神健康工具，都促進了市場的擴張。神經回饋和腦刺激設備在臨床和公眾中都獲得了越來越多的認可，這得益於越來越多的同行評審研究以及主要市場對非侵入性設備的有利法規環境。

高成本阻礙了其在大眾市場的滲透。

先進的神經回饋頭戴裝置、經顱刺激設備及其配套軟體平台的高昂價格是阻礙其廣泛普及的主要障礙。 NeuroCalm Tech 的許多產品仍屬於高階市場，這限制了其用戶群體，僅限於對價格敏感的消費者和報銷預算有限的醫療機構。此外，消費者神經健康設備缺乏標準化的保險覆蓋範圍也限制了機構的採購。如果硬體成本無法大幅降低，報銷機制不能更清晰，市場滲透率仍將集中在高所得群體和專業臨床機構。

與企業健康生態系的整合

企業越來越意識到，認知能力和壓力管理是提高員工生產力和留任率的關鍵因素。企業健康計畫的擴展為NeuroCalm Tech供應商提供了一個強大的管道，使其能夠實現規模化的B2B分銷。基於訂閱的神經回饋平台，結合即時心理健康分析儀表板，與企業在職業健康和員工留任方面的投入相契合。透過與福利管理機構、職場健康平台和保險公司建立合作關係，NeuroCalm Tech公司能夠在大規模員工群體中累積臨床證據，同時創造可觀的、持續的收入來源。

神經設備監管方面的不確定性

NeuroCalm Tech的產品橫跨消費健康設備和臨床醫療設備兩大類別，這導致其在主要市場面臨複雜且不斷變化的法規環境。 FDA和CE等監管機構對產品功效聲明執行力度不一致，對銷售腦部刺激和監控設備的製造商帶來合規風險。在相鄰類別中，誇大產品功效聲明歷來會導致監管干預和產品召回。對人工智慧生成的神經學見解日益嚴格的審查，以及不斷演變的生物識別辨識資訊資料隱私法規，進一步加重了製造商在多個司法管轄區的合規負擔。

新冠疫情的影響

在全球因封鎖、遠距辦公壓力和醫療系統中斷而導致心理健康惡化的背景下，新冠疫情顯著提升了對NeuroCalm Tech產品的需求。 2020年和2021年，數位健康平台和家用神經回饋設備的普及率出現了顯著成長。遠端保健的興起加速了遠距神經監測技術融入臨床工作流程。疫情後的市場復甦鞏固了神經技術作為主流健康領域的地位，消費者和機構對提升心理表現和認知韌性的工具的持續投資，支撐著持續成長且遠超市場趨勢的需求。

在預測期內，智慧神經回饋頭戴裝置和穿戴式裝置細分市場預計將成為最大的細分市場。

由於智慧神經回饋頭戴裝置和穿戴式裝置在消費者健康、臨床治療和企業績效管理等廣泛應用情境中具有極高的適用性，預計在預測期內，這類裝置將佔據最大的市場佔有率。這些設備以穿戴式且非臨床的形式提供基於腦電圖（EEG）的即時腦活動回饋，使其成為神經反饋技術領域中最易於獲取且最具商業性擴充性的產品類型。居家腦力訓練的日益普及、消費者對整合正念功能的穿戴式裝置的興趣不斷成長，以及透過數位健康零售管道不斷擴大的分銷管道，都進一步鞏固了該細分市場的領先地位。

預計在預測期內，軟體和平台領域將實現最高的複合年成長率。

在預測期內，軟體和平台細分市場預計將實現最高的複合年成長率，這主要得益於人工智慧驅動的自我調整演算法、基於雲端的心理健康監測儀錶板以及用於個性化認知療法的行動應用生態系統的快速發展。軟體平台能夠實現持續的遠端監測、跨裝置的數據聚合以及僅靠硬體無法實現的個人化干涉方案。 SaaS訂閱模式的擴展、遠端保健整合技術的進步以及企業對人工智慧驅動的認知分析平台採購量的增加，正推動該細分市場在整個NeuroCalm Tech市場中實現最快的成長。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率。這得益於消費者較高的健康意識、完善的數位健康基礎設施以及對神經技術Start-Ups的強勁創業投資投資。美國是區域需求的主要驅動力，這得益於其在心理健康診所、企業健康計劃以及開展腦機介面（BCI）臨床試驗的研究機構中積累的豐富經驗。美國食品藥物管理局（FDA）對非侵入性神經刺激設備的積極監管態度以及雇主對認知健康提升的不斷成長的投資，將進一步鞏固北美在整個預測期內的市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、日本、韓國和澳洲都市區心理健康意識的快速提升。政府的心理健康政策、中產階級可支配收入的增加以及數位健康技術日益融入消費者生活方式，都在加速市場滲透。各地區的電子製造生態系統為具有成本競爭力的硬體開發提供了優勢，而遠端醫療的日益普及則為面向服務不足人群的人工智慧神經健康平台創建了可擴展的分銷管道。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要企業進行SWOT分析（最多3家公司）
區域細分
- 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Muse（InteraXon Inc.）
Emotiv Inc.
Neurable Inc.
Nuro Diagnostics
BrainCo Inc.
Flow Neuroscience AB
Neurosity Inc.
Halo Neuroscience（Halo Sport）
BrainsWay Ltd.
Cerephex Corporation
Thync Global Inc.
Kernel（HRL Laboratories, LLC）
Medtronic plc
Abbott Laboratories
Philips Healthcare
Garmin Ltd.
Natus Medical Incorporated
Synchron Inc.

簡介目錄圖表

Product Code: SMRC34334

According to Stratistics MRC, the Global NeuroCalm Tech Market is accounted for $0.9 billion in 2026 and is expected to reach $3.1 billion by 2034 growing at a CAGR of 15.7% during the forecast period. NeuroCalm Tech encompasses a category of neuroscience-driven devices and digital platforms designed to monitor, regulate, and improve brain and mental health through non-invasive interventions. These solutions include EEG-based headsets, transcranial stimulation devices, smart sleep optimization systems, and AI-powered cognitive wellness apps that work together to address conditions such as anxiety, sleep disorders, ADHD, and PTSD. By combining wearable hardware with adaptive software and telehealth services, NeuroCalm Tech enables individuals, clinicians, and organizations to take a proactive, personalized approach to mental performance and neurological well-being.

Market Dynamics:

Driver:

Rising Mental Health Awareness Driving Adoption

Growing global awareness of mental health disorders and their economic and social consequences is creating strong demand for technology-driven wellness solutions. Accelerating stress levels in corporate environments, increasing prevalence of anxiety and sleep-related disorders, and growing consumer willingness to invest in preventive mental health tools are collectively expanding the addressable market. Neurofeedback and brain stimulation devices are gaining credibility across clinical and consumer settings alike, supported by a pipeline of peer-reviewed research and favorable regulatory pathways for non-invasive devices in major markets.

Restraint:

High Cost Limiting Mass Market Penetration

The substantial price points associated with advanced neurofeedback headsets, transcranial stimulation devices, and supporting software platforms represent a significant barrier to widespread consumer adoption. Many NeuroCalm Tech products remain positioned in premium segments, limiting access among price-sensitive demographics and healthcare systems with constrained reimbursement budgets. Additionally, the absence of standardized insurance coverage for consumer-grade neuro-wellness devices restricts institutional procurement. Without meaningful reductions in hardware costs and clearer reimbursement frameworks, market penetration will remain concentrated in high-income segments and specialized clinical settings.

Opportunity:

Integration with Corporate Wellness Ecosystems

Enterprises increasingly recognize cognitive performance and stress management as critical components of workforce productivity and retention. The growing adoption of corporate wellness programs presents a compelling channel for NeuroCalm Tech providers to achieve scalable B2B distribution. Subscription-based neurofeedback platforms, combined with real-time mental state analytics dashboards, align with employer investments in occupational health and talent retention. Partnerships with benefits administrators, workplace health platforms, and insurance carriers position NeuroCalm Tech companies to capture significant recurring revenue streams while building clinical evidence bases across large employee cohorts.

Threat:

Regulatory Uncertainty Around Neuro Device Claims

The dual classification challenge for NeuroCalm Tech products, spanning consumer wellness gadgets and clinical medical devices, creates complex and evolving regulatory environments across key markets. Inconsistent enforcement of efficacy claims by agencies such as the FDA and CE regulatory bodies introduces compliance risk for manufacturers marketing brain stimulation and monitoring devices. Overreaching product claims have previously prompted regulatory interventions and product withdrawals in adjacent categories. Heightened scrutiny of AI-generated neurological insights and evolving data privacy regulations for biometric information further elevate the compliance burden across multiple jurisdictions.

Covid-19 Impact

The COVID-19 pandemic significantly elevated demand for NeuroCalm Tech products as global mental health deteriorated amid lockdowns, remote work stress, and healthcare disruption. Digital wellness platforms and at-home neurofeedback devices experienced notable adoption spikes during 2020 and 2021. Telehealth normalization accelerated the integration of remote neuro-monitoring into clinical workflows. Post-pandemic market recovery has reinforced neurotechnology as a mainstream wellness category, with sustained consumer and institutional investment in mental performance and cognitive resilience tools continuing to support above-trend demand trajectories.

The smart neurofeedback headsets and wearables segment is expected to be the largest during the forecast period

The smart neurofeedback headsets and wearables segment is expected to account for the largest market share during the forecast period, owing to its broad applicability across consumer wellness, clinical therapy, and corporate performance management use cases. These devices deliver real-time EEG-based brain activity feedback in a wearable, non-clinical format, making them the most accessible and commercially scalable product category within the NeuroCalm Tech landscape. Rising consumer adoption of at-home brain training, growing interest in mindfulness-integrated wearables, and expanding distribution through digital health retail channels collectively reinforce this segment's dominant market position.

The software and platforms segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the software and platforms segment is expected to register the highest CAGR during the forecast period, driven by rapid advancement in AI-driven neuroadaptive algorithms, cloud-based mental health monitoring dashboards, and mobile application ecosystems for personalized cognitive therapy. Software platforms enable continuous remote monitoring, data aggregation across devices, and personalized intervention programming that hardware alone cannot deliver. Growing SaaS-based subscription models, expanding telehealth integration, and increasing enterprise procurement of AI-powered cognitive analytics platforms are propelling this segment to the fastest growth trajectory across the NeuroCalm Tech market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, underpinned by high consumer health awareness, well-developed digital health infrastructure, and robust venture capital investment in neurotechnology startups. The United States dominates regional demand, supported by a large installed base of mental health clinics, corporate wellness programs, and research institutions conducting brain-computer interface trials. Favorable FDA regulatory engagement with non-invasive neurostimulation devices and growing employer investment in cognitive health benefits further cement North America's commanding market leadership throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapidly rising mental health awareness among urban populations in China, Japan, South Korea, and Australia. Government mental health initiatives, expanding middle-class disposable income, and growing integration of digital wellness technologies into consumer lifestyles are accelerating market penetration. Regional electronics manufacturing ecosystems provide cost-competitive hardware development advantages, while increasing telehealth adoption creates scalable distribution channels for AI-powered neuro-wellness platforms across underserved populations.

Key players in the market

Some of the key players in NeuroCalm Tech Market include include Muse (InteraXon Inc.), Emotiv Inc., Neurable Inc., Nuro Diagnostics, BrainCo Inc., Flow Neuroscience AB, Neurosity Inc., Halo Neuroscience (Halo Sport), BrainsWay Ltd., Cerephex Corporation, Thync Global Inc., Kernel (HRL Laboratories, LLC), Medtronic plc, Abbott Laboratories, Philips Healthcare, Garmin Ltd., Natus Medical Incorporated, and Synchron Inc.

Key Developments:

In February 2026, Medtronic plc announced advancements in implantable neurostimulation devices targeting anxiety and mood disorders. These systems combine precision neuromodulation with remote monitoring, strengthening Medtronic's role in digital therapeutics.

In January 2026, Flow Neuroscience AB unveiled a new transcranial direct current stimulation (tDCS) headset for depression management. The innovation integrates app-based tracking, supporting accessible and clinically validated mental health solutions.

In November 2025, Muse (InteraXon Inc.) introduced its next-generation neurofeedback headband with enhanced AI-driven meditation guidance. The device improves stress reduction outcomes and supports personalized mental wellness programs.

Product Types Covered:

Smart Neurofeedback Headsets and Wearables
Transcranial Stimulation Devices
EEG-Based Brain Monitoring Systems
Smart Sleep Optimization Devices
Stress and Anxiety Management Gadgets
Cognitive Enhancement Patches
Neuro-Acoustic Therapy Devices

Components Covered:

Hardware
Software and Platforms
Services

Technologies Covered:

Electroencephalography (EEG)
Transcranial Direct Current Stimulation (tDCS)
Transcranial Magnetic Stimulation (TMS)
Biofeedback and Neurofeedback Technology
AI-Driven Neuroadaptive Algorithms
Photobiomodulation (Light-Based Neuro Therapy)
Vibro-Acoustic and Sound Frequency Technology

Applications Covered:

Stress and Anxiety Reduction
Sleep Disorder Management
Cognitive Performance Enhancement
PTSD and Trauma Recovery
ADHD Management
Mental Wellness and Mindfulness

End Users Covered:

Individual Consumers and Wellness Seekers
Hospitals and Psychiatric Centers
Corporate Wellness Programs
Defense and Military Organizations
Sports and Athletic Performance Institutions
Research and Academic Institutions

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global NeuroCalm Tech Market, By Product Type

5.1 Smart Neurofeedback Headsets & Wearables
5.2 Transcranial Stimulation Devices
5.3 EEG-Based Brain Monitoring Systems
5.4 Smart Sleep Optimization Devices
5.5 Stress & Anxiety Management Gadgets
5.6 Cognitive Enhancement Patches
5.7 Neuro-Acoustic Therapy Devices

6 Global NeuroCalm Tech Market, By Component

6.1 Hardware
- 6.1.1 Neuro Sensors & Electrode Arrays
- 6.1.2 Signal Processing Units
- 6.1.3 Stimulation Modules
6.2 Software & Platforms
- 6.2.1 Neuroadaptive Apps & Mobile Platforms
- 6.2.2 AI-Based Stress Analytics Software
- 6.2.3 Cloud-Based Monitoring Dashboards
6.3 Services
- 6.3.1 Personalized Therapy Programs
- 6.3.2 Remote Monitoring & Telehealth Services

7 Global NeuroCalm Tech Market, By Technology

7.1 Electroencephalography (EEG)
7.2 Transcranial Direct Current Stimulation (tDCS)
7.3 Transcranial Magnetic Stimulation (TMS)
7.4 Biofeedback & Neurofeedback Technology
7.5 AI-Driven Neuroadaptive Algorithms
7.6 Photobiomodulation (Light-Based Neuro Therapy)
7.7 Vibro-Acoustic & Sound Frequency Technology

8 Global NeuroCalm Tech Market, By Application

8.1 Stress & Anxiety Reduction
8.2 Sleep Disorder Management
8.3 Cognitive Performance Enhancement
8.4 PTSD & Trauma Recovery
8.5 ADHD Management
8.6 Mental Wellness & Mindfulness

9 Global NeuroCalm Tech Market, By End User

9.1 Individual Consumers & Wellness Seekers
9.2 Hospitals & Psychiatric Centers
9.3 Corporate Wellness Programs
9.4 Defense & Military Organizations
9.5 Sports & Athletic Performance Institutions
9.6 Research & Academic Institutions

10 Global NeuroCalm Tech Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 Muse (InteraXon Inc.)
13.2 Emotiv Inc.
13.3 Neurable Inc.
13.4 Nuro Diagnostics
13.5 BrainCo Inc.
13.6 Flow Neuroscience AB
13.7 Neurosity Inc.
13.8 Halo Neuroscience (Halo Sport)
13.9 BrainsWay Ltd.
13.10 Cerephex Corporation
13.11 Thync Global Inc.
13.12 Kernel (HRL Laboratories, LLC)
13.13 Medtronic plc
13.14 Abbott Laboratories
13.15 Philips Healthcare
13.16 Garmin Ltd.
13.17 Natus Medical Incorporated
13.18 Synchron Inc.

簡介目錄圖表

List of Tables

Table 1 Global NeuroCalm Tech Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global NeuroCalm Tech Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global NeuroCalm Tech Market Outlook, By Smart Neurofeedback Headsets & Wearables (2023-2034) ($MN)
Table 4 Global NeuroCalm Tech Market Outlook, By Transcranial Stimulation Devices (2023-2034) ($MN)
Table 5 Global NeuroCalm Tech Market Outlook, By EEG-Based Brain Monitoring Systems (2023-2034) ($MN)
Table 6 Global NeuroCalm Tech Market Outlook, By Smart Sleep Optimization Devices (2023-2034) ($MN)
Table 7 Global NeuroCalm Tech Market Outlook, By Stress & Anxiety Management Gadgets (2023-2034) ($MN)
Table 8 Global NeuroCalm Tech Market Outlook, By Cognitive Enhancement Patches (2023-2034) ($MN)
Table 9 Global NeuroCalm Tech Market Outlook, By Neuro-Acoustic Therapy Devices (2023-2034) ($MN)
Table 10 Global NeuroCalm Tech Market Outlook, By Component (2023-2034) ($MN)
Table 11 Global NeuroCalm Tech Market Outlook, By Hardware (2023-2034) ($MN)
Table 12 Global NeuroCalm Tech Market Outlook, By Neuro Sensors & Electrode Arrays (2023-2034) ($MN)
Table 13 Global NeuroCalm Tech Market Outlook, By Signal Processing Units (2023-2034) ($MN)
Table 14 Global NeuroCalm Tech Market Outlook, By Stimulation Modules (2023-2034) ($MN)
Table 15 Global NeuroCalm Tech Market Outlook, By Software & Platforms (2023-2034) ($MN)
Table 16 Global NeuroCalm Tech Market Outlook, By Neuroadaptive Apps & Mobile Platforms (2023-2034) ($MN)
Table 17 Global NeuroCalm Tech Market Outlook, By AI-Based Stress Analytics Software (2023-2034) ($MN)
Table 18 Global NeuroCalm Tech Market Outlook, By Cloud-Based Monitoring Dashboards (2023-2034) ($MN)
Table 19 Global NeuroCalm Tech Market Outlook, By Services (2023-2034) ($MN)
Table 20 Global NeuroCalm Tech Market Outlook, By Personalized Therapy Programs (2023-2034) ($MN)
Table 21 Global NeuroCalm Tech Market Outlook, By Remote Monitoring & Telehealth Services (2023-2034) ($MN)
Table 22 Global NeuroCalm Tech Market Outlook, By Technology (2023-2034) ($MN)
Table 23 Global NeuroCalm Tech Market Outlook, By Electroencephalography (EEG) (2023-2034) ($MN)
Table 24 Global NeuroCalm Tech Market Outlook, By Transcranial Direct Current Stimulation (tDCS) (2023-2034) ($MN)
Table 25 Global NeuroCalm Tech Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2023-2034) ($MN)
Table 26 Global NeuroCalm Tech Market Outlook, By Biofeedback & Neurofeedback Technology (2023-2034) ($MN)
Table 27 Global NeuroCalm Tech Market Outlook, By AI-Driven Neuroadaptive Algorithms (2023-2034) ($MN)
Table 28 Global NeuroCalm Tech Market Outlook, By Photobiomodulation (Light-Based Neuro Therapy) (2023-2034) ($MN)
Table 29 Global NeuroCalm Tech Market Outlook, By Vibro-Acoustic & Sound Frequency Technology (2023-2034) ($MN)
Table 30 Global NeuroCalm Tech Market Outlook, By Application (2023-2034) ($MN)
Table 31 Global NeuroCalm Tech Market Outlook, By Stress & Anxiety Reduction (2023-2034) ($MN)
Table 32 Global NeuroCalm Tech Market Outlook, By Sleep Disorder Management (2023-2034) ($MN)
Table 33 Global NeuroCalm Tech Market Outlook, By Cognitive Performance Enhancement (2023-2034) ($MN)
Table 34 Global NeuroCalm Tech Market Outlook, By PTSD & Trauma Recovery (2023-2034) ($MN)
Table 35 Global NeuroCalm Tech Market Outlook, By ADHD Management (2023-2034) ($MN)
Table 36 Global NeuroCalm Tech Market Outlook, By Mental Wellness & Mindfulness (2023-2034) ($MN)
Table 37 Global NeuroCalm Tech Market Outlook, By End User (2023-2034) ($MN)
Table 38 Global NeuroCalm Tech Market Outlook, By Individual Consumers & Wellness Seekers (2023-2034) ($MN)
Table 39 Global NeuroCalm Tech Market Outlook, By Hospitals & Psychiatric Centers (2023-2034) ($MN)
Table 40 Global NeuroCalm Tech Market Outlook, By Corporate Wellness Programs (2023-2034) ($MN)
Table 41 Global NeuroCalm Tech Market Outlook, By Defense & Military Organizations (2023-2034) ($MN)
Table 42 Global NeuroCalm Tech Market Outlook, By Sports & Athletic Performance Institutions (2023-2034) ($MN)
Table 43 Global NeuroCalm Tech Market Outlook, By Research & Academic Institutions (2023-2034) ($MN)